<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7121811\results\search\drugs\results.xml">
  <result pre="good ARV activity with nonsevere toxic effects in comparison with" exact="nevirapine" post="as the standard drug in positive control group (Ardestani"/>
  <result pre="use was summarized by Gao et al. (2018). For example," exact="tenofovir" post="(TFV) alafenamide and elvitegravir (EVG) loaded NPs subcutaneously administered"/>
  <result pre="Gao et al. (2018). For example, tenofovir (TFV) alafenamide and" exact="elvitegravir" post="(EVG) loaded NPs subcutaneously administered to female humanized CD34+-NSG"/>
  <result pre="Jiang et al. (2015) incorporated ARV drugs maraviroc, etravirine, and" exact="raltegravir" post="into poly(lactic-co-glycolic) acid (PLGA) NPs and found that ARV"/>
  <result pre="in vitro was estimated mainly for ARV NPs combinations involving" exact="etravirine" post="NPs, whereby the combinations that showed large dose-reduction were"/>
  <result pre="a biodegradable carrier for loading with TFV in combination with" exact="efavirenz" post="or saquinavir, which resulted in pronounced combination drug effects,"/>
  <result pre="(0.01861 and 0.033 μg/mL, respectively) and showed comparable activity with" exact="emtricitabine" post="solution. Based on prolonged intracellular drug concentration and inhibition"/>
  <result pre="and reduced toxicity of ARV bioactives. Surface-functionalized mannosylated-PLGA NPs of" exact="lamivudine" post="(LVD) administered by intravenous route in a dose of"/>
  <result pre="(MP) delivery system (NiMDS) comprised of pure NPs of the" exact="darunavir" post="(DRV) and its boosting agent ritonavir (RTV) encapsulated within"/>
  <result pre="pure NPs of the darunavir (DRV) and its boosting agent" exact="ritonavir" post="(RTV) encapsulated within film-coated MPs was reported, in which"/>
  <result pre="succinate derivatives of NRTIs with cholesteryl-ε-polylysine nanogels. Nanogel conjugates of" exact="zidovudine" post="(ZDV), LVD, and abacavir demonstrated tenfold suppression of reverse"/>
  <result pre="with cholesteryl-ε-polylysine nanogels. Nanogel conjugates of zidovudine (ZDV), LVD, and" exact="abacavir" post="demonstrated tenfold suppression of reverse transcriptase activity in HIV-infected"/>
  <result pre="constructed CD4-targeted SLNPs providing selective binding and efficient delivery of" exact="indinavir" post="to CD4+-HIV host cells (whereby inclusion of PEG in"/>
  <result pre="use in HIV/AIDS therapy (Joshy et al. 2018b). ZDV-loaded core-shell" exact="dextran" post="hybrid nanosystem expressed enhanced cellular internalization of drug-loaded hybrid"/>
  <result pre="Retained intracytoplasmic nanoformulations consisting of a hydrophobic and lipophilic modified" exact="dolutegravir" post="prodrug encapsulated into poloxamer released the drug from macrophages"/>
  <result pre="of a hydrophobic and lipophilic modified dolutegravir prodrug encapsulated into" exact="poloxamer" post="released the drug from macrophages and suppressed viral replication"/>
  <result pre="the living cells (Amirkhanov et al. 2015). SeNPs decorated by" exact="ribavirin" post="(RBV), a broad-spectrum antiviral drug, protected cells during H1N1"/>
  <result pre="(Tang et al. 2018). Biomimetic supramolecular hexagonal-shaped nanoassemblies composed of" exact="chondroitin sulfate" post="formed by mixing hydrophobically modified chondroitin sulfate with α-cyclodextrin"/>
  <result pre="nanoassemblies composed of chondroitin sulfate formed by mixing hydrophobically modified" exact="chondroitin sulfate" post="with α-cyclodextrin in water showed improved antiviral activity against"/>
  <result pre="showed improved antiviral activity against HSV-2 compared to hydrophobically modified" exact="chondroitin sulfate" post="(Galus et al. 2016). ACV was found to increasingly"/>
  <result pre="C (Hang et al. 2015). Multifunctional SeNPs with baicalin and" exact="folic acid" post="surface-modifications designed for the targeted treatment of HBV-infected liver"/>
  <result pre="immune responses (Yang et al. 2016b). HBsAg-loaded trimethyl CS (TMC)/hydroxypropyl" exact="methylcellulose" post="(hypromellose) phthalate (HPMCP) NPs with particle size of 158"/>
  <result pre="delivery system prepared by conjugating the liver-targeting peptide to PEGylated" exact="cyclosporine" post="A-encapsulated PLGA NPs effectively inhibited viral replication in vitro"/>
  <result pre="in mice and non-human primatesNPJ Vaccines201834610.1038/s41541-018-0086-030302284 BelgamwarAKhanSYeolePIntranasal chitosan-g-HPβCD nanoparticles of" exact="efavirenz" post="for the CNS targetingArtif Cells Nanomed Biotechnol20184637438610.1080/21691401.2017.131326628423949 BernasconiVBernocchiBYeLLeMQOmokanyeACarpentierRSchonKSaelensXStaeheliPBetbederDLyckeNPorous nanoparticles"/>
  <result pre="doseProc Natl Acad Sci U S A2016113E4133E414210.1073/pnas.160029911327382155 ChaowanachanTKrogstadEBallCWoodrowKADrug synergy of" exact="tenofovir" post="and nanoparticle-based antiretrovirals for HIV prophylaxisPLoS One20138e6141610.1371/journal.pone.006141623630586 ChatziprodromidouIPArvanitidouMGuitianJApostolouTVantarakisGApostolos VantarakisAGlobal"/>
  <result pre="type 1Bioconjug Chem2017281115112210.1021/acs.bioconjchem.7b0003028177606 DesaiJThakkarHEnhanced oral bioavailability and brain uptake of" exact="darunavir" post="using lipid nanoemulsion formulationColloids Surf B: Biointerfaces201917514314910.1016/j.colsurfb.2018.11.05730529999 DeyPBergmannTCuellar-CamachoJLEhrmannSChowdhuryMSZhangMZDahmaniIHaagRAzadWMultivalent flexible"/>
  <result pre="disease and H9N2 AI virusesVet World20171018719310.14202/vetworld.2017.187-19328344402 EndsleyANHoRJYEnhanced anti-HIV efficacy of" exact="indinavir" post="after inclusion in CD4-targeted lipid nanoparticlesJ Acquir Immune Defic"/>
  <result pre="3Int J Nanomedicine201384303431424235828 GaldieroSFalangaAVitielloMCantisaniMMarraVGaldieroMSilver nanoparticles as potential antiviral agentsMolecules2011168894891810.3390/molecules1610889422024958 GalusAMalletJMLemboDCagnoVDjabourovMLortat-JacobHBouchemalKHexagonal-shaped" exact="chondroitin sulfate" post="self-assemblies have exalted anti-HSV-2 activityCarbohydr Polym201613611312010.1016/j.carbpol.2015.08.05426572336 GaoYKraftJCYuDHoRJYRecent developments of"/>
  <result pre="against HIV infection in the brainNanomedicine20141017718510.1016/j.nano.2013.06.01223845925 GongYuqingChowdhuryPallabitaMiddeNarasimha M.RahmanMohammad A.YallapuMurali M.KumarSantoshNovel" exact="elvitegravir" post="nanoformulation approach to suppress the viral load in HIV-infected"/>
  <result pre="for the formulation and optimization of solid lipid nanoparticles of" exact="efavirenz" post="by high pressure homogenization using design of experiments for"/>
  <result pre="transmitted infection—an updateMicrobial Cell2016342043710.15698/mic2016.09.52728357379 IshiharaTKanekoKIshiharaTMizushimaTDevelopment of biodegradable nanoparticles for liver-specific" exact="ribavirin" post="deliveryJ Pharm Sci20141034005401110.1002/jps.2421925335768 IshwaryaRVaseeharanBAnuradhaRRekhaRGovindarajanMAlharbiNSKadaikunnanSKhaledJMBenelliGEco-friendly fabrication of Ag nanostructures using"/>
  <result pre="and nanoparticle vaccines against the respiratory syncytial virusVaccine201644510.3390/vaccines4040045 JoshyKSAlexSMSnigdhaSKalarikkalNPothenLAThomasSEncapsulation of" exact="zidovudine" post="in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug"/>
  <result pre="nanoparticles for anti viral drug deliveryChem Phys Lipids2018210828910.1016/j.chemphyslip.2017.11.00329129570 JoshyKSGeorgeASnigdhaSJosephBKalarikkalNPothenLAThomasSNovel core-shell" exact="dextran" post="hybrid nanosystem for anti-viral drug deliveryMater Sci Eng C"/>
  <result pre="carboxy methyl cellulose and compritol-PEG for antiretroviral drug deliveryCellulose2017244759477110.1007/s10570-017-1446-z JyothiKRBeloorJJoAMinhNNChoiTGKimJHAkterSLeeSKMaengCHBaikHHKangIHaJKimSSLiver-targeted" exact="cyclosporine" post="A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus"/>
  <result pre="of influenza infectionVet Sci201857110.3390/vetsci50300716165133 KumarPLakshmiYSBhaskarCGollaKKondapiAKImproved safety, bioavailability and pharmacokinetics of" exact="zidovudine" post="through lactoferrin nanoparticles during oral administration in ratsPLoS One201510e014039910.1371/journal.pone.014039926461917"/>
  <result pre="transcriptase inhibitory potentialJ Clust Sci20172835936710.1007/s10876-016-1100-1 KumarPLakshmiYSKondapiAKTriple drug combination of zidovudine," exact="efavirenz" post="and lamivudine loaded lactoferrin nanoparticles: an effective nano first-line"/>
  <result pre="potentialJ Clust Sci20172835936710.1007/s10876-016-1100-1 KumarPLakshmiYSKondapiAKTriple drug combination of zidovudine, efavirenz and" exact="lamivudine" post="loaded lactoferrin nanoparticles: an effective nano first-line regimen for"/>
  <result pre="of H1N1 influenza virus infection by selenium nanoparticles loaded with" exact="ribavirin" post="via resisting caspase-3 apoptotic pathwayInt J Nanomedicine2018135787579710.2147/IJN.S17765830310281 LuLSunRWYChenRHuiCKHoCMLukJMLauGKKCheCMSilver nanoparticles"/>
  <result pre="treatment of HIV infectionAntimicrob Agents Chemother201761e01475e0141610.1128/AAC.01475-1627821449 MandalSPrathipatiPKKangGBZhouYYuanZFanWJLiQSDestacheCJTenofovir alafenamide and and" exact="elvitegravir" post="loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmissionAIDS20173146947610.1097/QAD.000000000000134928121666"/>
  <result pre="Biol Rev20056946250010.1128/MMBR.69.3.462-500.200516148307 PrathipatiPKMandalSPonGVivekanandanRDestacheCJPharmacokinetic and tissue distribution profile of long acting" exact="tenofovir" post="alafenamide and elvitegravir loaded nanoparticles in humanized mice modelPharm"/>
  <result pre="and tissue distribution profile of long acting tenofovir alafenamide and" exact="elvitegravir" post="loaded nanoparticles in humanized mice modelPharm Res2017342749275510.1007/s11095-017-2255-728905173 QiMZhangXESunXXZhangXWYaoYFLiuSLChenZLiWZhangZPChenJJCuiZIntranasal nanovaccine"/>
 </snippets>
</snippetsTree>
